PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3050% below fair value
$23.78+0.24 (+1.02%)
Close on Nov 17, 2026Market cap $1.36BP/E –Yield –
PROCEPT BioRobotics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
PROCEPT BioRobotics's operating cash flow for the twelve months ending Jun 30, 2026 was -$74.34M. For fiscal 2025 it was -$48.99M. The highest annual figure on record is -$48.34M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$48.99M | – |
| FY2024 | Dec 31, 2024 | -$99.21M | – |
| FY2023 | Dec 31, 2023 | -$108.00M | – |
| FY2022 | Dec 31, 2022 | -$80.38M | – |
| FY2021 | Dec 31, 2021 | -$57.33M | – |
| FY2020 | Dec 31, 2020 | -$48.34M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$19.25M | – |
| Q1 FY2026 | Mar 31, 2026 | -$38.13M | – |
| Q4 FY2025 | Dec 31, 2025 | -$10.33M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.64M | – |
| Q2 FY2025 | Jun 30, 2025 | -$15.04M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$32.39M | – |
| Q3 FY2024 | Sep 30, 2024 | -$18.80M | – |
| Q2 FY2024 | Jun 30, 2024 | -$15.74M | – |
| Q1 FY2024 | Mar 31, 2024 | -$32.29M | – |
| Q4 FY2023 | Dec 31, 2023 | -$24.79M | – |
| Q3 FY2023 | Sep 30, 2023 | -$18.94M | – |
| Q2 FY2023 | Jun 30, 2023 | -$28.34M | – |
| Q1 FY2023 | Mar 31, 2023 | -$35.93M | – |
| Q4 FY2022 | Dec 31, 2022 | -$25.17M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.85M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.13M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.23M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.48M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.75M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.91M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.20M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.45M | – |
See a number that looks wrong?